UK Biopharmaceutical Excipients Market Size & Outlook
Related Markets
UK biopharmaceutical excipients market highlights
- The UK biopharmaceutical excipients market generated a revenue of USD 198.9 million in 2025 and is expected to reach USD 338.6 million by 2033.
- The UK market is expected to grow at a CAGR of 6.9% from 2026 to 2033.
- In terms of segment, solubilizes & surfactants/emulsifiers was the largest revenue generating product in 2025.
- Specialty Excipients is the most lucrative product segment registering the fastest growth during the forecast period.
Biopharmaceutical excipients market data book summary
| Market revenue in 2025 | USD 198.9 million |
| Market revenue in 2033 | USD 338.6 million |
| Growth rate | 6.9% (CAGR from 2026 to 2033) |
| Largest segment | Solubilizes & surfactants/emulsifiers |
| Fastest growing segment | Specialty Excipients |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Specialty Excipients, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates |
| Key market players worldwide | Merck KGaA, Basf SE, Associated British Foods PLC, IMCD NV, Clariant AG, Evonik Industries AG, Colorcon, Sigachi, Spectrum Chemical Manufacturingrp, Roquette America, DFE Pharma, J. Rettenmaier & Söhne |
Other key industry trends
- In terms of revenue, UK accounted for 6.3% of the global biopharmaceutical excipients market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany biopharmaceutical excipients market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 338.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Excipients Market Scope
Biopharmaceutical Excipients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| J. Rettenmaier & Söhne | View profile | 101-250 | Holzmühle, Sachsen, Germany, Europe | https://www.jrs.eu |
| DFE Pharma | View profile | 251-500 | Goch, Nordrhein-Westfalen, Germany, Europe | https://www.dfepharma.com/ |
| Sigachi | View profile | 501-1000 | Hyderabad, Andhra Pradesh, India, Asia | https://sigachi.com |
| Spectrum Chemical Manufacturingrp | View profile | 101-250 | New Brunswick, New Jersey, United States, North America | https://www.spectrumchemical.com |
| Colorcon | View profile | 1001-5000 | Harleysville, Pennsylvania, United States, North America | https://www.colorcon.com |
| IMCD NV | View profile | 4948 | Wilhelminaplein 32, Rotterdam, Netherlands, 3072 DE | https://www.imcdgroup.com |
| Roquette America | View profile | 5001-10000 | Gurnee, Illinois, United States, North America | https://www.roquette.com/ |
| Clariant AG | View profile | 10481 | Rothausstrasse 61, Muttenz, Switzerland, 4132 | http://www.clariant.com |
| Associated British Foods PLC | View profile | 133000 | 10 Grosvenor Street, Weston Centre, London, United Kingdom, W1K 4QY | https://www.abf.co.uk |
| Evonik Industries AG | View profile | 33409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | https://www.evonik.com |
| Basf SE | View profile | 111855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | https://www.basf.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
UK biopharmaceutical excipients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.
Solubilizes & surfactants/emulsifiers was the largest segment with a revenue share of 38.21% in 2025. Horizon Databook has segmented the UK biopharmaceutical excipients market based on specialty excipients, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2021 to 2033.
The UK biopharmaceutical market has potential strengths and opportunities favoring the growing use of excipients. Top three segments that account for the maximum share in the UK biopharmaceutical market include small molecules, therapeutic proteins, and antibodies.
For instance, “Invest in Great Britain and Northern Ireland” is one such initiative undertaken by UK government. Through this initiative the government offers guidelines to overseas businesses, offering them advice and support to set up businesses in the UK.
Reasons to subscribe to UK biopharmaceutical excipients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK biopharmaceutical excipients market databook
-
Our clientele includes a mix of biopharmaceutical excipients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK biopharmaceutical excipients market , including forecasts for subscribers. This country databook contains high-level insights into UK biopharmaceutical excipients market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
UK biopharmaceutical excipients market size, by product, 2021-2033 (US$M)
UK Biopharmaceutical Excipients Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
